Barbara Lead was the Chief Executive Officer of Cambridge Pharma and Oval Medical Technologies (both now SMC Ltd) until 2023. Ms Lead has held senior positions in three pharma companies and has experience in R&D and industrialisation. Working in the field of asthma and allergy, she has experience working with a variety of drug-device combination products and in solving manufacturing and design issues with drug delivery devices. Over many years, Ms Lead has come to realise the importance of good device design, risk assessment and human factors in the development of delivery devices to ensure effective drug delivery and correct use by patients.